BVT Aktienanleihe ML 30.01.2025/ DE000VM8QU95 /
27.05.2024 09:20:05 | Diff.0.00 | Geld09:55:00 | Brief09:55:00 | Basiswert | Basispreis | Fälligkeit | Optionsart |
---|---|---|---|---|---|---|---|
100.75EUR | 0.00% | 100.74 Geld Vol: 500'000 |
100.84 Brief Vol: 500'000 |
Cie Generale des Eta... | 26.18 EUR | 30.01.2025 | Call |
GlobeNewswire
10:00
Samsung Bioepis Announces Oral Presentation on Switching Period Results for SB16, a Proposed Biosimi...
GlobeNewswire
10:00
TDOC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Teladoc Health, Inc. Investors...
GlobeNewswire
10:00
GDRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GoodRx Holdings, Inc. Investor...
GlobeNewswire
10:00
SHCR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sharecare Inc. Investors with ...
GlobeNewswire
10:00
VFS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that VinFast Auto Ltd. (f/k/a Black ...
GlobeNewswire
10:00
QDEL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Investors with Sub...
GlobeNewswire
10:00
INTC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Intel Corporation Investors wi...
GlobeNewswire
07:00
Press Release: Sarclisa accepted for FDA priority review for the treatment of transplant-ineligible ...
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite